The cross-reactivity of the ER-PE24 variants with both human and murine EGFR facilitated the comparison of the antitumor efficacy and systemic toxicity of ER-PE24 ITs with the highest and intermediate affinity for EGFR in the EGFR-overexpressing tumor xenograft mouse model. The gene discussed is EGFR; the disease is neoplasm.